EDX/20/1154
Date of prep: December 2020
Prescribing information and
adverse events reporting
For healthcare professionals only
EDX/20/1154
Date of prep: December 2020
Prescribing information and
adverse events reporting
For healthcare professionals only
The Royal Pharmaceutical Society (RPS) is examining its fellowship processes. They have stated that this is to ensure the process is ‘fair and equitable’. The move comes as part of their inclusion and diversity strategy.
In particular, RPS is reviewing their fellowship nomination and appointment process. RPS have said that this is to ensure that any barriers to eligibility are removed. To check there is consistency in assessing how members have made an exceptional contribution to pharmacy, RPS is taking the following action:
RPS Chief Executive Paul Bennett said:
“We are fully committed to embedding inclusion and diversity across RPS and reviewing our processes is part of this. I know what an honour it is to receive this accolade and we want to ensure the exceptional talents of all pharmacists are recognised in a consistent way.”
Chair of the RPS Fellows Panel Dr Gill Hawksworth said:
“I welcome this review. We want to ensure fairness and equality are at the heart of our assessment process so that excellence can be celebrated regardless of individual backgrounds.”
Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.
This site is for healthcare professionals, please confirm you are a healthcare professional to continue.
Begin the discussion right here